Vita Life Sciences Ltd (ASX:VLS) Stock Price, Trades & News

Vita Life Sciences Ltd is an Australian-based pharmaceutical and healthcare company involved in formulating, packaging, selling, and distributing vitamins and supplements. It produces a wide range of premium supplements, vitamins, minerals, herbs, and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, VitaScience, and Herbs of Gold brands throughout the Asia-Pacific region. Vita Life Sciences has two operating segments: VMS Operational, which generates maximum revenue, and VMS Investments. Geographically, the Group generates maximum revenue from Malaysia and Singapore, and the rest from Australia, and China and Vietnam.

Financial Strength

8/10

Name	Current	Vs Industry
Cash-To-Debt	14.86
Equity-to-Asset	0.68
Debt-to-Equity	0.04
Debt-to-EBITDA	0.16
Interest Coverage	39.84
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	5.53	Distress Grey Safe
Beneish M-Score	-2.65	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

7/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	9.8
	3-Year EBITDA Growth Rate	9.6
	3-Year EPS without NRI Growth Rate	12
	3-Year FCF Growth Rate	78.6
	3-Year Book Growth Rate	16.2

Momentum Rank

8/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	57.38
	9-Day RSI	53.11
	14-Day RSI	51.57
	3-1 Month Momentum %	-1.16
	6-1 Month Momentum %	0.79
	12-1 Month Momentum %	7.56

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	2.72
	Quick Ratio	2.1
	Cash Ratio	1.47
	Days Inventory	155.69
	Days Sales Outstanding	50.43
	Days Payable	77.51

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	5.6
	Dividend Payout Ratio	0.6
	3-Year Dividend Growth Rate	23.8
	Forward Dividend Yield %	5.6
	5-Year Yield-on-Cost %	15.32
	3-Year Average Share Buyback Ratio	0.6
	Shareholder Yield %	5.89

Profitability Rank

10/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	61.15
	Operating Margin %	15.08
	Net Margin %	11.19
	EBITDA Margin %	15.85
	FCF Margin %	17
	OCF Margin %	17.61
	ROE %	19.41
	ROA %	13.68
	ROIC %	30.57
	3-Year ROIIC %	45
	ROC (Joel Greenblatt) %	70.61
	ROCE %	26.83
	Years of Profitability over Past 10-Year	10

GF Value Rank

6/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	13.66
	PE Ratio without NRI	13.66
	Shiller PE Ratio	19.61
	Price-to-Owner-Earnings	12.82
	PEG Ratio	1.59
	PS Ratio	1.52
	PB Ratio	2.47
	Price-to-Tangible-Book	2.48
	Price-to-Free-Cash-Flow	8.99
	Price-to-Operating-Cash-Flow	8.68
	EV-to-EBIT	6.95
	EV-to-EBITDA	6.95
	EV-to-Revenue	1.1
	EV-to-FCF	6.45
	Price-to-GF-Value	1.01
	Price-to-Projected-FCF	0.92
	Price-to-DCF (Earnings Based)	0.63
	Price-to-DCF (FCF Based)	0.41
	Price-to-Median-PS-Value	1.09
	Price-to-Peter-Lynch-Fair-Value	1.58
	Price-to-Graham-Number	1.23
	Price-to-Net-Current-Asset-Value	3.47
	Price-to-Net-Cash	14.71
	Earnings Yield (Greenblatt) %	14.4
	FCF Yield %	11.67
	Forward Rate of Return (Yacktman) %	14.66

GF Value™: A$2.47

ASX:VLS

Warning Signs

Warning! GuruFocus detected 1 Severe warning sign with VLS. Try a 7-Day Free Trial to check it out.

Vita Life Sciences Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Vita Life Sciences Ltd Stock Events

Financials Calendars

Event	Date	Price (A$)
AUD 0.095000 Cash Dividend	2026-03-27	2.57 (+0.00%)
AUD 0.045000 Cash Dividend	2025-09-19	2.56 (+1.59%)
AUD 0.065000 Cash Dividend	2025-03-21	1.93 (+0.00%)
AUD 0.035000 Cash Dividend	2024-09-20	2.33 (-0.64%)
1:1 Stock Split	2009-07-01	0.20 (-4.76%)

Show

Entries

Press Release

	Subject	Date
No Press Release

Articles on Vita Life Sciences Ltd

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.